Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group PURPOSE: To characterize the clinical and biologic features of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results